The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohmura-Hoshino, M.
Right arrow Articles by Ishido, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohmura-Hoshino, M.
Right arrow Articles by Ishido, S.
The Journal of Immunology, 2006, 177: 341-354.
Copyright © 2006 by The American Association of Immunologists

Inhibition of MHC Class II Expression and Immune Responses by c-MIR1

Mari Ohmura-Hoshino2,*, Yohei Matsuki2,*, Masami Aoki*, Eiji Goto*,{ddagger}, Mari Mito*, Mika Uematsu*, Terutaka Kakiuchi{dagger}, Hak Hotta{ddagger} and Satoshi Ishido3,*

* Laboratory for Infectious Immunity, The Institute of Physical and Chemical Research (RIKEN), Research Center for Allergy and Immunology, Yokohama, Kanagawa, Japan; {dagger} Department of Immunology, Toho University School of Medicine, Tokyo, Japan; and {ddagger} Division of Microbiology, Department of Genome Sciences, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan

We previously reported a novel E3 ubiquitin ligase (E3), designated as c-MIR, which targets B7-2 to lysosomal degradation and down-regulates the B7-2 surface expression through ubiquitination of its cytoplasmic tail. B7-2 is well known as a costimulatory molecule for Ag presentation, suggesting that the manipulation of c-MIR expression modulates immune responses in vivo. To examine this hypothesis, we generated genetically modified mice in which c-MIR was expressed under an invariant chain (Ii) promoter. Dendritic cells derived from genetically engineered mice showed low ability to present Ags. In addition, these mice showed resistance to the onset of experimental autoimmune encephalomyelitis and an impaired development of CD4 T cells in the thymus and the periphery. These findings led us to conclude that MHC class II (MHC II) is an additional target for c-MIR. Indeed, forced expression of c-MIR in several B cell lines down-regulated the surface expression of MHC II, and down-regulation was found to depend on the presence of a single lysine residue in the cytoplasmic tail of the I-A beta-chain. In a reconstitution system using 293T cells, we found that the lysine residue at position 225 in the I-A beta-chain was ubiquitinated by c-MIR. To our knowledge, c-MIR is the first example of an E3 that is capable of inhibiting MHC II expression. Our findings suggest that c-MIR might potently regulate immune responses in vivo.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. De Gassart, V. Camosseto, J. Thibodeau, M. Ceppi, N. Catalan, P. Pierre, and E. Gatti
MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation
PNAS, March 4, 2008; 105(9): 3491 - 3496.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
K.G. S. Kumar, H. Barriere, C. J. Carbone, J. Liu, G. Swaminathan, P. Xu, Y. Li, D. P. Baker, J. Peng, G. L. Lukacs, et al.
Site-specific ubiquitination exposes a linear motif to promote interferon-{alpha} receptor endocytosis
J. Cell Biol., December 3, 2007; 179(5): 935 - 950.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. J. Young, N. S. Wilson, P. Schnorrer, A. Mount, R. J. Lundie, N. L. La Gruta, B. S. Crabb, G. T. Belz, W. R. Heath, and J. A. Villadangos
Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens
PNAS, November 6, 2007; 104(45): 17753 - 17758.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Barriere, C. Nemes, K. Du, and G. L. Lukacs
Plasticity of Polyubiquitin Recognition as Lysosomal Targeting Signals by the Endosomal Sorting Machinery
Mol. Biol. Cell, October 1, 2007; 18(10): 3952 - 3965.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Obst, H.-M. van Santen, R. Melamed, A. O. Kamphorst, C. Benoist, and D. Mathis
Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation
PNAS, September 25, 2007; 104(39): 15460 - 15465.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. L. Herrmann, R. S. Agrawal, S. F. Connolly, R. L. McCaffrey, J. Schlomann, and D. J. Kusner
MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II
J. Leukoc. Biol., September 1, 2007; 82(3): 686 - 699.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Morokuma, N. Nakamura, A. Kato, M. Notoya, Y. Yamamoto, Y. Sakai, H. Fukuda, S. Yamashina, Y. Hirata, and S. Hirose
MARCH-XI, a Novel Transmembrane Ubiquitin Ligase Implicated in Ubiquitin-dependent Protein Sorting in Developing Spermatids
J. Biol. Chem., August 24, 2007; 282(34): 24806 - 24815.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Y. Kuwano, C. M. Prazma, N. Yazawa, R. Watanabe, N. Ishiura, A. Kumanogoh, H. Okochi, K. Tamaki, M. Fujimoto, and T. F. Tedder
CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells
Int. Immunol., August 1, 2007; 19(8): 977 - 992.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. M. Traub and G. L. Lukacs
Decoding ubiquitin sorting signals for clathrin-dependent endocytosis by CLASPs
J. Cell Sci., February 15, 2007; 120(4): 543 - 553.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.